In addition, ELMO3 positive/higher expression is associated with poor overall survival in non-small cell lung cancer and head and neck cancer, as well as in breast cancer, corroborating its role as an oncogene [43, 44]. The gene discussed is ELMO3; the disease is breast cancer.